Abstract
ObjectivesTo establish the safety of an intranasal diamorphine (IND) spray in children.DesignAn open-label, single-dose pharmacovigilance trial.SettingEmergency departments in eight UK hospitals.ParticipantsChildren aged 2–16 years with a fracture or other trauma.Outcome...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
